IRIS MELANOMA
Clinical trials for IRIS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new IRIS MELANOMA trials appear
Sign up with your email to follow new studies for IRIS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Pronged attack on deadly eye cancer
Disease control OngoingThis study is testing whether taking one of two oral medications—sunitinib or valproic acid—for 6 to 12 months can help prevent a high-risk form of eye melanoma from spreading to other parts of the body after initial treatment. It involves 210 patients who have already had their …
Matched conditions: IRIS MELANOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
First human test: using Patients' own immune cells to fight advanced skin cancer
Disease control OngoingThis early-stage study is testing a personalized treatment called TBio-4101 for people with advanced melanoma that hasn't responded to standard therapies. Doctors take immune cells from a patient's tumor, grow them in large numbers in a lab, and then infuse them back into the pat…
Matched conditions: IRIS MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC